Adma Biologics (ADMA) Cash & Equivalents (2011 - 2026)
Adma Biologics (ADMA) posted Cash & Equivalents of $124.56 million for Q3 2026, up 102.9% from $61.39 million a year earlier but down 8.4% from the prior quarter.
Powered by 
Analysis
Adma Biologics (ADMA) Cash & Equivalents (2011 - 2026) Analysis & Trends
At the end of FY2025, Adma Biologics' Cash & Equivalents came in at $87.63 million, down 15.0% from FY2024.
- Annual Cash & Equivalents shows a five-year compound annual growth rate of 9.4% (FY2020 to FY2025).
- In prior years, Adma Biologics' Cash & Equivalents was $103.15 million in FY2024 (+100.9%), $51.35 million in FY2023 (-40.6%), $86.52 million in FY2022 (+69.4%) and $51.09 million in FY2021 (-8.6%).
- Quarterly Cash & Equivalents has run from a low of $34.91 million in Q3 2022 to a high of $138.15 million in Q1 2026 over five years.
- On a year-over-year basis, Cash & Equivalents has increased in each of the last three quarters, with growth averaging 45.4% over the last eight quarters.
- The strongest year-over-year quarter for Cash & Equivalents in the past five years was Q3 2023, with growth of 112.4%; the weakest was Q4 2023, with a decline of 40.6%.
- According to Business Quant data, Cash & Equivalents for the three prior quarters was $136.02 million (Q2 2026), $138.15 million (Q1 2026) and $87.63 million (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,261.99 Bn | 1,235.61 Bn | 20.46 Bn | 4.89 Bn |
| 2 | Johnson & Johnson | 678.93 Bn | 598.79 Bn | 17.30 Bn | 16.91 Bn |
| 3 | AbbVie | 518.29 Bn | 486.30 Bn | 13.12 Bn | 10.77 Bn |
| 4 | Merck | 365.98 Bn | 328.92 Bn | 13.19 Bn | 9.55 Bn |
| 5 | Novartis Ag | 316.85 Bn | 290.09 Bn | - | 400.00 Mn |
| 6 | Astrazeneca | 293.40 Bn | 267.29 Bn | 13.26 Bn | 7.94 Bn |
| 7 | Amgen | 251.78 Bn | 203.43 Bn | 7.58 Bn | 13.19 Bn |
| 8 | Gilead Sciences | 210.61 Bn | 185.71 Bn | 6.73 Bn | 6.44 Bn |
| 9 | Pfizer | 166.87 Bn | 114.23 Bn | 12.56 Bn | 1.82 Bn |
| 10 | Adma Biologics | 2.87 Bn | 2.39 Bn | 99.92 Mn | 124.56 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 124.56 Mn |
| Jun 30, 2026 | 136.02 Mn |
| Mar 31, 2026 | 138.15 Mn |
| Dec 31, 2025 | 87.63 Mn |
| Sep 30, 2025 | 61.39 Mn |
| Jun 30, 2025 | 90.29 Mn |
| Mar 31, 2025 | 71.63 Mn |
| Dec 31, 2024 | 103.15 Mn |
| Sep 30, 2024 | 86.71 Mn |
| Jun 30, 2024 | 88.24 Mn |
| Mar 31, 2024 | 45.33 Mn |
| Dec 31, 2023 | 51.35 Mn |
| Sep 30, 2023 | 74.16 Mn |
| Jun 30, 2023 | 62.51 Mn |
| Mar 31, 2023 | 69.20 Mn |
| Dec 31, 2022 | 86.52 Mn |
| Sep 30, 2022 | 34.91 Mn |
| Jun 30, 2022 | 52.42 Mn |
| Mar 31, 2022 | 69.50 Mn |
| Dec 31, 2021 | 51.09 Mn |
API Access
Adma Biologics Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=ADMA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "ADMA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=ADMA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();